Page 12 - Analytical Solutions News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Revvity (NYSE:RVTY – Get Rating) and Singular Genomics Systems (NASDAQ:OMIC – Get Rating) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, earnings, institutional ownership and dividends. Analyst Recommendations This is a breakdown of recent ratings and […]

Singular Genomics Systems (NASDAQ:OMIC – Get Rating) and Revvity (NYSE:RVTY – Get Rating) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, dividends, analyst recommendations and earnings. Valuation and Earnings This table compares Singular Genomics Systems and […]

The Goldman Sachs Group started coverage on shares of Revvity (NYSE:RVTY – Get Rating) in a research note released on Tuesday, The Fly reports. The firm issued a buy rating on the stock. Revvity Trading Down 0.6 % RVTY stock opened at $116.45 on Tuesday. The company has a current ratio of 2.43, a quick […]

The Goldman Sachs Group assumed coverage on shares of Revvity (NYSE:RVTY – Get Rating) in a research report sent to investors on Tuesday morning, The Fly reports. The brokerage issued a buy rating on the stock. Revvity Price Performance Shares of NYSE RVTY opened at $120.30 on Tuesday. The company has a current ratio of […]

PerkinElmer (NYSE:PKI – Get Rating) had its target price lowered by equities research analysts at Citigroup from $170.00 to $160.00 in a report released on Monday, The Fly reports. Citigroup’s price target would indicate a potential upside of 38.84% from the company’s current price. A number of other research firms have also recently issued reports […]